Background/Purpose: Recent studies have shown high rates of autoantibody production in patients hospitalized with COVID-19, including antinuclear antibodies (ANA) and antibodies associated with antiphospholipid syndrome. However, the long-term implications of these phenomena remain unknown. Similarly, whether vaccination against SARS-CoV-2 with novel mRNA constructs may lead to an increase in autoantibody production (or clinically evident autoimmunity) … Continue reading Low Incidence and Transient Elevation of Autoantibodies Post mRNA COVID-19 Vaccination